Condition: Ovarian Cancer · Ascites · Sponsor: British Columbia Cancer Agency
The objective of the study is to investigate the metabolism of cells in the ascites tumour microenvironment of ovarian cancer patients. This observational study involves intravenous infusion of \[U-13C\]glucose into patients during standard paracentesis.
This description comes directly from the study's public registry record.
Julian J. Lum, PhD · 250-519-5700 · JLum@bccancer.bc.ca
Jennifer Rauw, MD · 250-519-5500 · Jennifer.Rauw@bccancer.bc.ca
Always discuss trial participation with your own doctor first.
| Jennifer Rauw | Victoria, British Columbia, Canada | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05025878